Impact of HPV Education on Knowledge, Awareness, and Concern

NCT ID: NCT07110909

Last Updated: 2025-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

103 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-01

Study Completion Date

2025-04-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled study is being conducted between January and April 2025 at a Family Health Center in the Black Sea Region with 103 women (intervention group: 50, control group: 53) selected via randomizer.org. Participants complete pre-tests, receive HPV and cervical cancer prevention education, and take post-tests to evaluate the impact of the intervention.

Keywords: HPV, education, knowledge, awareness, midwife.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is designed as a randomized controlled trial aimed at evaluating the impact of educational interventions on HPV awareness, knowledge levels, and concerns among women. The research is being carried out at a Family Health Center in the Black Sea Region between January and April 2025. A total of 103 women have been selected through randomizer.org and assigned to either the intervention group (n=50) or control group (n=53).

Participants are initially assessed using a Personal Information Form, the HPV Knowledge Scale, and the HPV Awareness and Concern Scale. The intervention group receives structured education on HPV and cervical cancer prevention delivered by midwives and healthcare professionals. Post-tests are planned to assess potential changes in the measured variables. The study emphasizes the importance of healthcare-based education in improving public awareness and preventive health behaviors.

Keywords: HPV, education, knowledge, awareness, prevention, midwife, cervical cancer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Papilloma Virus (HPV)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

experimental group: 50; control group: 53
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No HPV Education

Control group without HPV education.

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental

Participants received HPV education to increase awareness and prevention of cervical cancer

Group Type EXPERIMENTAL

HPV Education

Intervention Type OTHER

HPV Education

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HPV Education

HPV Education

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being a woman aged 18-49
* Not having received any previous education about HPV
* Volunteering to participate in the study and providing written consent

Exclusion Criteria

* Having been diagnosed with HPV or being in treatment
* Having previously received information or counselling about HPV
* Refusing or withdrawing from the education and data collection process
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gizem ÇITAK

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gizem ÇITAK

Assistant Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GİZEM ÇITAK, Asist. Prof

Role: PRINCIPAL_INVESTIGATOR

Tokat Gaziosmanpaşa University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tokat Gaziosmanpaşa University Rectorate General Secretariat Taşlıçiftlik Campus, 60250 Tokat/Central

Tokat Province, Center, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K22.05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Knowledge and Attitude About HPV Vaccines
NCT01043341 COMPLETED PHASE4